Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line
暂无分享,去创建一个
Takeshi Iwamura | Toshiaki Setoguchi | Shoji Taniguchi | Norio Kitamura | Hideo Yamanari | N. Kitamura | T. Iwamura | S. Taniguchi | H. Yamanari | T. Setoguchi
[1] A. Kojima,et al. Correlation between CA19‐9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT‐2) , 1992, Journal of gastroenterology and hepatology.
[2] L. Liotta,et al. Activation of human breast carcinoma collagenase through plasminogen activator. , 1980, Life sciences.
[3] T. Iwamura,et al. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. , 1987, Japanese journal of cancer research : Gann.
[4] I. Hart. The selection and characterization of an invasive variant of the B16 melanoma. , 1979, The American journal of pathology.
[5] L. Liotta,et al. Role of laminin in the attachment and metastasis of murine tumor cells. , 1982, Cancer research.
[6] H. Okazaki,et al. High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line. , 1989, Cancer research.
[7] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[8] L. Liotta,et al. Partial purification and characterization of a neutral protease which cleaves type IV collagen. , 1981, Biochemistry.
[9] A. Granelli‐Piperno,et al. A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.
[10] I. Ramshaw,et al. Involvement of plasminogen activator production with tumor metastasis in a rat model. , 1984, Cancer research.
[11] W. Stetler-Stevenson. Type IV collagenases in tumor invasion and metastasis , 1990, Cancer and Metastasis Reviews.
[12] I. Fidler,et al. Thein vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants , 1989, Clinical & Experimental Metastasis.
[13] C. Claudianos,et al. Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma. , 1986, Invasion & metastasis.
[14] U. Thorgeirsson,et al. Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. , 1990, Cancer research.
[15] L. Liotta,et al. Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[16] E. Ishikawa,et al. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder. , 1989, Cancer research.
[17] R. Stephens,et al. Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator , 1981, International journal of cancer.
[18] D. Maslow. Tabulation of results on the heterogeneity of cellular characteristics among cells from B16 mouse melanoma cell lines with different colonization potentials. A summary of sixty reports. , 1989, Invasion and Metastasis.
[19] J. Richie,et al. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. , 1980, Cancer research.
[20] T. Iwamura,et al. Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines , 1992, Clinical & Experimental Metastasis.
[21] G. Martin,et al. Basement membrane and the invasive activity of metastatic tumor cells. , 1986, Journal of the National Cancer Institute.
[22] L. Matrisian,et al. Stromelysin in tumor progression and metastasis , 1990, Cancer and Metastasis Reviews.